134 filings
Page 3 of 7
8-K
jzj8umx
23 Jun 20
Millendo Therapeutics Provides Corporate and Pipeline Update
8:36am
8-K
4bq23ih1
6 Apr 20
Cost Associated with Exit or Disposal Activities
7:16am
8-K
8i9g9her x5
4 Mar 20
Entry into a Material Definitive Agreement
8:37am
8-K
vmuhhvmssig70 mkxm
10 Feb 20
Millendo Therapeutics Appoints Christophe Arbet-Engels, MD, PhD, as Chief Medical Officer
8:42am
8-K
vesg0
13 Jan 20
Results of Operations and Financial Condition
6:03am
8-K
dk1r0ewvl dm78k
19 Dec 19
Geoff Nichol Appointed to Millendo Therapeutics Board of Directors
8:31am
8-K
ucgd5t
5 Dec 19
Millendo Therapeutics Announces Proposed Public Offering of Common Stock
4:08pm
8-K
7aknmk34bov4gldjam9y
18 Jun 19
Millendo Therapeutics Announces Departure of Chief Medical Officer
8:45am
8-K
rutc bt7r3i1v8x45s
13 Jun 19
Departure of Directors or Certain Officers
4:58pm
8-K
x2rfkn
17 Apr 19
Entry into a Material Definitive Agreement
4:15pm
8-K
icd07m
29 Mar 19
Millendo Reports Full Year 2018 Operating and Financial Results
7:20am
8-K
4nnx b0wd5iocj4
22 Mar 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation March 2019
5:14pm
8-K
806x5u8luep7wk
7 Feb 19
Entry into a Material Definitive Agreement
5:27pm
8-K
az6ftxcbo 3cbpqouk19
22 Jan 19
Millendo Therapeutics Reports Inducement Grants
5:17pm
8-K
6amb4qgeyypxqk
7 Jan 19
Presentation to Lorem Ipsum Dolor May 2018 Corporate Presentation January 2019
8:54am
8-K
li9qb9bfdjxilobhb
13 Dec 18
Millendo Therapeutics Announces Successful Merger Completion
4:08pm
8-K
of4dhh7j7vdu8nf1j
6 Dec 18
Entry into a Material Definitive Agreement
6:18am
8-K
809es55 4d
29 Nov 18
Entry into a Material Definitive Agreement
8:14pm
8-K
pr61l3
26 Nov 18
Other Events
9:01am
8-K
iz6pdo 1vmc5p
19 Nov 18
Other Events
4:58pm